In addition, the authors demonstrated that cyclin dependent kinase regulatory subunit 2 (CKS2) in the cell cycle dependent protein kinase subunit family, as a novel tumor biomarker, is highly expressed in HCC and that its elevated expression is predictive of poorer prognosis and tumor progression (Zhang et al., 2019). The gene discussed is CKS2; the disease is hepatocellular carcinoma.